LANSOPRAZOLE BGR 15 mg, gastro-resistant capsule 30 capsules, CIP 3400934410642
Active ingredients: Lansoprazole
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule30 capsules, CIP 3400934410642orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LANSOPRAZOLE BGR 15 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 30 gélule(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut etre pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Reflux gastro-oesophagien et oesophagite associée<br>- Ulcère duodénal<br>- Prévention des lésions gastro-duodénales induites par les anti-inflammatoires non stéroidiens ; JOURNAL OFFICIEL ; 18/06/02
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Jul 2017
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69847275CIP73441064CIP133400934410642Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LANSOPRAZOLEgélule | 15 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.